AGN,Valeant increases bid for Botox-maker AllerganCANADA STOCKS-Valeant leads decline as TSX hits one-week lowUS STOCKS-Wall St dips; S&P; holds above 1,900 after hitting new peakUPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      * Indexes off: Dow 0.2 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to morning trading, adds comment, Vivus)UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.        US STOCKS-Wall St dips; S&P; holds above 1,900 after hitting new peakUPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      * Indexes off: Dow 0.2 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to morning trading, adds comment, Vivus)UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       * TSX falls 91.73 points, or 0.63 percent, to 14,566.29     * Nine of the 10 main index sectors decline     * Valeant drops 3.6 percent after raising Allergan bid      By John Tilak     TORONTO, May 28 Canada's main stock index fell to its lowest in a week on Wednesday, hit by a decline in shares of Valeant Pharmaceuticals International Inc after the drugmaker raised its takeover offer for Allergan Inc.     Valeant's stock gave back 3 percent after the company increased the cash compUS STOCKS-Wall St dips; S&P; holds above 1,900 after hitting new peakUPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      * Indexes off: Dow 0.2 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to morning trading, adds comment, Vivus)UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.         CANADA STOCKS-Valeant leads decline as TSX hits one-week lowUS STOCKS-Wall St dips; S&P; holds above 1,900 after hitting new peakUPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      * Indexes off: Dow 0.2 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to morning trading, adds comment, Vivus)UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.        US STOCKS-Wall St dips; S&P; holds above 1,900 after hitting new peakUPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      * Indexes off: Dow 0.2 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to morning trading, adds comment, Vivus)UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       * TSX falls 91.73 points, or 0.63 percent, to 14,566.29     * Nine of the 10 main index sectors decline     * Valeant drops 3.6 percent after raising Allergan bid      By John Tilak     TORONTO, May 28 Canada's main stock index fell to its lowest in a week on Wednesday, hit by a decline in shares of Valeant Pharmaceuticals International Inc after the drugmaker raised its takeover offer for Allergan Inc.     Valeant's stock gave back 3 percent after the company increased the cash compUS STOCKS-Wall St dips; S&P; holds above 1,900 after hitting new peakUPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      * Indexes off: Dow 0.2 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to morning trading, adds comment, Vivus)UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.        May 28 Canadian drugmaker Valeant Pharmaceuticals International Inc raised the cash component of its offer for Botox-maker Allergan Inc by $10 per share.CANADA STOCKS-Valeant leads decline as TSX hits one-week lowUS STOCKS-Wall St dips; S&P; holds above 1,900 after hitting new peakUPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      * Indexes off: Dow 0.2 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to morning trading, adds comment, Vivus)UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.        US STOCKS-Wall St dips; S&P; holds above 1,900 after hitting new peakUPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      * Indexes off: Dow 0.2 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to morning trading, adds comment, Vivus)UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       * TSX falls 91.73 points, or 0.63 percent, to 14,566.29     * Nine of the 10 main index sectors decline     * Valeant drops 3.6 percent after raising Allergan bid      By John Tilak     TORONTO, May 28 Canada's main stock index fell to its lowest in a week on Wednesday, hit by a decline in shares of Valeant Pharmaceuticals International Inc after the drugmaker raised its takeover offer for Allergan Inc.     Valeant's stock gave back 3 percent after the company increased the cash compUS STOCKS-Wall St dips; S&P; holds above 1,900 after hitting new peakUPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.       UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      * Indexes off: Dow 0.2 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to morning trading, adds comment, Vivus)UPDATE 3-Nestle boosts skincare business with $1.4 bln Valeant dealValeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.      Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     * Valeant says deal clears way for it to buy Allergan   (Adds more analyst comments, background)Valeant may take offer directly to Allergan investors - CEOValeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.     Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    May 28 Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.Valeant may take offer directly to Allergan investors - CEOUS STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.    US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   Valeant Pharmaceuticals Inc  may take its $49.44 billion takeover bid for Botox-maker Allergan Inc  directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.US STOCKS-Wall St flat as S&P; 500 holds near latest recordUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.   UPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  * Valeant raises cash component of Allergan bid; shares fallUPDATE 4-Valeant injects cash into bid for Botox maker AllerganValeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.  Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped. May 28 Canada's Valeant Pharmaceuticals International Inc  raised the cash component of its unsolicited offer for Botox maker Allergan Inc on Wednesday, but the increased bid fell short of expectations and both stocks dropped.Valeant injects cash into bid for Botox maker Allergan Canada's Valeant Pharmaceuticals International Inc   raised the cash component of its unsolicited offer for Botox maker Allergan Inc  on Wednesday, but the increased bid fell short of expectations and both stocks dropped.         
GOOGL,Google building self-driving cars with no driver seat, steering wheelsGoogle building self-driving cars with no driver seat, steering wheels RANCHO PALOS VERDES Calif. Google Inc is building cars that don't have steering wheels, accelerator pedals or brake pedals, in an ambitious expansion of the Internet company's efforts to develop self-driving cars.  Google building self-driving cars with no driver seat, steering wheels RANCHO PALOS VERDES Calif. Google Inc is building cars that don't have steering wheels, accelerator pedals or brake pedals, in an ambitious expansion of the Internet company's efforts to develop self-driving cars. RANCHO PALOS VERDES, Calif., May 27 Google Inc  is building cars that don't have steering wheels, accelerator pedals or brake pedals, in an ambitious expansion of the Internet company's efforts to develop self-driving cars.Google building self-driving cars with no driver seat, steering wheels RANCHO PALOS VERDES Calif. Google Inc is building cars that don't have steering wheels, accelerator pedals or brake pedals, in an ambitious expansion of the Internet company's efforts to develop self-driving cars.  
GOOG,Google building self-driving cars with no driver seat, steering wheelsGoogle building self-driving cars with no driver seat, steering wheels RANCHO PALOS VERDES Calif. Google Inc is building cars that don't have steering wheels, accelerator pedals or brake pedals, in an ambitious expansion of the Internet company's efforts to develop self-driving cars.  Google building self-driving cars with no driver seat, steering wheels RANCHO PALOS VERDES Calif. Google Inc is building cars that don't have steering wheels, accelerator pedals or brake pedals, in an ambitious expansion of the Internet company's efforts to develop self-driving cars. RANCHO PALOS VERDES, Calif., May 27 Google Inc  is building cars that don't have steering wheels, accelerator pedals or brake pedals, in an ambitious expansion of the Internet company's efforts to develop self-driving cars.Google building self-driving cars with no driver seat, steering wheels RANCHO PALOS VERDES Calif. Google Inc is building cars that don't have steering wheels, accelerator pedals or brake pedals, in an ambitious expansion of the Internet company's efforts to develop self-driving cars.  
AMZN,UPDATE 2-Amazon says quick end unlikely in dispute with HachetteLagardere targets growth, downplays Amazon row PARIS French media group Lagardere has targeted organic annual revenue growth of more than 3 percent through to 2018, helped by new markets and online sales, and said a dispute with online retailer Amazon would not affect 2014 sales.  Lagardere targets growth, downplays Amazon row PARIS French media group Lagardere has targeted organic annual revenue growth of more than 3 percent through to 2018, helped by new markets and online sales, and said a dispute with online retailer Amazon would not affect 2014 sales. * Hachette operating in 'good faith' but two sides at odds -AmazonLagardere targets growth, downplays Amazon row PARIS French media group Lagardere has targeted organic annual revenue growth of more than 3 percent through to 2018, helped by new markets and online sales, and said a dispute with online retailer Amazon would not affect 2014 sales.  
AIG,Ex-AIG chief Greenberg loses bid to end New York lawsuit NEW YORK, May 28 A New York state judge has rejected a request by Maurice "Hank" Greenberg, the former American International Group Inc chief executive officer, to dismiss a long-running civil  lawsuit by the state's attorney general. 
AMGN,CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  
APC,Anadarko's $5.15 bln cleanup agreement clears first court hurdle NEW YORK, May 28 Anadarko Petroleum Corp's  agreement to pay $5.15 billion to clean up nuclear fuel and other pollution moved one step closer to reality on Wednesday, receiving a bankruptcy judge's rubber stamp. 
AAPL,UPDATE 1-Japan's Renesas to sell display chip business to Synaptics -sourcesAustralian Apple users report "lost phone" cyber attackAustralian Apple users report 'lost phone' cyber attackApple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  SAN FRANCISCO/SYDNEY Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.    Australian Apple users report 'lost phone' cyber attackApple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  SAN FRANCISCO/SYDNEY Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   SAN FRANCISCO/SYDNEY, May 28 Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Australian Apple users report 'lost phone' cyber attackApple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  SAN FRANCISCO/SYDNEY Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.     Australian Apple users report "lost phone" cyber attackAustralian Apple users report 'lost phone' cyber attackApple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  SAN FRANCISCO/SYDNEY Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.    Australian Apple users report 'lost phone' cyber attackApple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  SAN FRANCISCO/SYDNEY Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   SAN FRANCISCO/SYDNEY, May 28 Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Australian Apple users report 'lost phone' cyber attackApple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  SAN FRANCISCO/SYDNEY Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.    * Renesas SP Driver is chip supplier for Apple iPhone screensAustralian Apple users report "lost phone" cyber attackAustralian Apple users report 'lost phone' cyber attackApple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  SAN FRANCISCO/SYDNEY Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.    Australian Apple users report 'lost phone' cyber attackApple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  SAN FRANCISCO/SYDNEY Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   SAN FRANCISCO/SYDNEY, May 28 Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Australian Apple users report 'lost phone' cyber attackApple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.   Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  SAN FRANCISCO/SYDNEY Multiple users on Apple Inc's online support forum and Twitter have reported an unusual smartphone and tablet hack in which cyber attackers were said to have locked Australian users' smartphones and demanded payment in return for unlocking them.Apple to buy Beats for about $3 blnUPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.  UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming. May 28 Apple Inc said it would buy headphone maker Beats Electronics and streaming music provider Beats Music for about $3 billion.UPDATE 2-Apple to get Beats, music mogul Iovine for $3 bln SAN FRANCISCO, May 28 Apple Inc will buy Beats for about $3 billion and bring recording mogul Jimmy Iovine into its ranks, hoping to win points with the music industry and help it catch up in fast-growing music streaming.     
BLK,Blackrock's Fink says letter to CEOs triggered angry phone callsUPDATE 1-BlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  BOSTON BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.    "I've had some really angry phone calls," Fink said at a New York investment conference hosted by Sanford Bernstein.BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)    BlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  BOSTON BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.    "I've had some really angry phone calls," Fink said at a New York investment conference hosted by Sanford Bernstein.BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BOSTON, May 28 BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.BlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  BOSTON BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.    "I've had some really angry phone calls," Fink said at a New York investment conference hosted by Sanford Bernstein.BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)     UPDATE 1-BlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  BOSTON BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.    "I've had some really angry phone calls," Fink said at a New York investment conference hosted by Sanford Bernstein.BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)    BlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  BOSTON BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.    "I've had some really angry phone calls," Fink said at a New York investment conference hosted by Sanford Bernstein.BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BOSTON, May 28 BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.BlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  BOSTON BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.    "I've had some really angry phone calls," Fink said at a New York investment conference hosted by Sanford Bernstein.BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)    BOSTON, May 28 Blackrock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said on Wednesday he has fielded angry phone calls over a letter he sent in March to S&P; 500 executives that warned them about the perils of short-term thinking.UPDATE 1-BlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  BOSTON BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.    "I've had some really angry phone calls," Fink said at a New York investment conference hosted by Sanford Bernstein.BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)    BlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  BOSTON BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.    "I've had some really angry phone calls," Fink said at a New York investment conference hosted by Sanford Bernstein.BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BOSTON, May 28 BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.BlackRock's Fink says letter to CEOs triggered angry phone callsBlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)   BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  BOSTON BlackRock Inc Chief Executive Larry Fink, who runs the world's largest asset manager, said Wednesday he had fielded angry phone calls after he sent a letter in March to S&P; 500 executives warning them about the perils of short-term thinking.    "I've had some really angry phone calls," Fink said at a New York investment conference hosted by Sanford Bernstein.BlackRock CEO says leveraged ETFs could 'blow up' whole industryUPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)  UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5) May 28 BlackRock Inc Chief Executive Larry Fink said on Wednesday that leveraged exchange-traded funds contain structural problems that could "blow up" the whole industry one day.UPDATE 4-BlackRock CEO says leveraged ETFs could 'blow up' whole industry (Adds comment from leveraged ETF firm ProShares in paragraphs 4-5)     
BA,CORRECTED-Boeing receives U.S. approval for wider 787 operationsUPDATE 1-Boeing 787 receives U.S. approval for extended operations WASHINGTON, May 28 The U.S. Federal Aviation Administration on Wednesday approved  extended operations for Boeing's 787 Dreamliner, a move that will allow a wider range of routes and that marks a vote of confidence in the high-tech jet at a time of renewed scrutiny.  UPDATE 1-Boeing 787 receives U.S. approval for extended operations WASHINGTON, May 28 The U.S. Federal Aviation Administration on Wednesday approved  extended operations for Boeing's 787 Dreamliner, a move that will allow a wider range of routes and that marks a vote of confidence in the high-tech jet at a time of renewed scrutiny. (Corrects second paragraph to say 5-1/2 instead of 6-1/2 hours)UPDATE 1-Boeing 787 receives U.S. approval for extended operations WASHINGTON, May 28 The U.S. Federal Aviation Administration on Wednesday approved  extended operations for Boeing's 787 Dreamliner, a move that will allow a wider range of routes and that marks a vote of confidence in the high-tech jet at a time of renewed scrutiny.  
BMY,CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  
CVX,Chevron shareholders reject independent chairChevron still interested in Ukraine project, CEO saysRPT UPDATE 1-Angola LNG shutdown to last until mid-2015CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  (Repeats to additional subscribers)  (Adds detail, market impact of prolonged shutdown)CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.    RPT UPDATE 1-Angola LNG shutdown to last until mid-2015CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  (Repeats to additional subscribers)  (Adds detail, market impact of prolonged shutdown)CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   MIDLAND, Texas, May 28 Chevron Corp  remains interested in developing shale gas deposits in western Ukraine and is monitoring closely the development of relations with Russia, Chief Executive John Watson said on Wednesday.RPT UPDATE 1-Angola LNG shutdown to last until mid-2015CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  (Repeats to additional subscribers)  (Adds detail, market impact of prolonged shutdown)CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.     Chevron still interested in Ukraine project, CEO saysRPT UPDATE 1-Angola LNG shutdown to last until mid-2015CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  (Repeats to additional subscribers)  (Adds detail, market impact of prolonged shutdown)CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.    RPT UPDATE 1-Angola LNG shutdown to last until mid-2015CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  (Repeats to additional subscribers)  (Adds detail, market impact of prolonged shutdown)CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   MIDLAND, Texas, May 28 Chevron Corp  remains interested in developing shale gas deposits in western Ukraine and is monitoring closely the development of relations with Russia, Chief Executive John Watson said on Wednesday.RPT UPDATE 1-Angola LNG shutdown to last until mid-2015CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  (Repeats to additional subscribers)  (Adds detail, market impact of prolonged shutdown)CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.    MIDLAND, Texas, May 28 Chevron Corp  shareholders rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.Chevron still interested in Ukraine project, CEO saysRPT UPDATE 1-Angola LNG shutdown to last until mid-2015CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  (Repeats to additional subscribers)  (Adds detail, market impact of prolonged shutdown)CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.    RPT UPDATE 1-Angola LNG shutdown to last until mid-2015CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  (Repeats to additional subscribers)  (Adds detail, market impact of prolonged shutdown)CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   MIDLAND, Texas, May 28 Chevron Corp  remains interested in developing shale gas deposits in western Ukraine and is monitoring closely the development of relations with Russia, Chief Executive John Watson said on Wednesday.RPT UPDATE 1-Angola LNG shutdown to last until mid-2015CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.   CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  (Repeats to additional subscribers)  (Adds detail, market impact of prolonged shutdown)CORRECTED-UPDATE 1-Chevron shareholders reject independent chairUPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.  UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson. (Corrects paragraph 2 to reflect that shareholder activists want corporations to split the chairman and CEO positions, instead of splice the positions)UPDATE 2-Chevron shareholders reject independent chairman MIDLAND, Texas, May 28 Shareholders of Chevron Corp, the second-largest U.S. oil company, rejected a proposal on Wednesday to split the roles of chairman and chief executive, both currently held by John Watson.     
COH,UPDATE 3-Michael Kors warns of margin pressure as it expands in Europe * Sees first-qtr revenue $840-$850 mln vs est. $826.1 mln 
XOM,BRIEF-Exxon CEO says Russia/Ukraine conflict has no impact on operationsExxon's Russian business unaffected by conflict -CEOUPDATE 2-Exxon's Russian business unaffected by Ukraine conflict -CEO DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Russian oil company Rosneft have so far not been disrupted by tensions between Russia and Ukraine or sanctions imposed by the United States, Exxon's CEO said on Wednesday.  UPDATE 2-Exxon's Russian business unaffected by Ukraine conflict -CEO DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Russian oil company Rosneft have so far not been disrupted by tensions between Russia and Ukraine or sanctions imposed by the United States, Exxon's CEO said on Wednesday. DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Rosneft  have so far not been disrupted by tensions between Russia and Ukraine, the company's CEO told shareholders on Wednesday.UPDATE 2-Exxon's Russian business unaffected by Ukraine conflict -CEO DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Russian oil company Rosneft have so far not been disrupted by tensions between Russia and Ukraine or sanctions imposed by the United States, Exxon's CEO said on Wednesday.   Exxon's Russian business unaffected by conflict -CEOUPDATE 2-Exxon's Russian business unaffected by Ukraine conflict -CEO DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Russian oil company Rosneft have so far not been disrupted by tensions between Russia and Ukraine or sanctions imposed by the United States, Exxon's CEO said on Wednesday.  UPDATE 2-Exxon's Russian business unaffected by Ukraine conflict -CEO DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Russian oil company Rosneft have so far not been disrupted by tensions between Russia and Ukraine or sanctions imposed by the United States, Exxon's CEO said on Wednesday. DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Rosneft  have so far not been disrupted by tensions between Russia and Ukraine, the company's CEO told shareholders on Wednesday.UPDATE 2-Exxon's Russian business unaffected by Ukraine conflict -CEO DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Russian oil company Rosneft have so far not been disrupted by tensions between Russia and Ukraine or sanctions imposed by the United States, Exxon's CEO said on Wednesday.  HOUSTON, May 28 Exxon Mobil Corp :  * CEO says conflict between Russia and ukraine has had no impact on its RussianExxon's Russian business unaffected by conflict -CEOUPDATE 2-Exxon's Russian business unaffected by Ukraine conflict -CEO DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Russian oil company Rosneft have so far not been disrupted by tensions between Russia and Ukraine or sanctions imposed by the United States, Exxon's CEO said on Wednesday.  UPDATE 2-Exxon's Russian business unaffected by Ukraine conflict -CEO DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Russian oil company Rosneft have so far not been disrupted by tensions between Russia and Ukraine or sanctions imposed by the United States, Exxon's CEO said on Wednesday. DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Rosneft  have so far not been disrupted by tensions between Russia and Ukraine, the company's CEO told shareholders on Wednesday.UPDATE 2-Exxon's Russian business unaffected by Ukraine conflict -CEO DALLAS, May 28Exxon Mobil Corp's  drilling operations in Russia and its partnership with Russian oil company Rosneft have so far not been disrupted by tensions between Russia and Ukraine or sanctions imposed by the United States, Exxon's CEO said on Wednesday.   
FB,Facebook seeks EU antitrust review of WhatsApp deal - sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceWRAPUP 3-Thai military rulers appoint anti-Thaksin advisersUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      UPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     * Appointed advisers include former generals close to palaceUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)       WRAPUP 3-Thai military rulers appoint anti-Thaksin advisersUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      UPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     * Appointed advisers include former generals close to palaceUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.WRAPUP 3-Thai military rulers appoint anti-Thaksin advisersUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      UPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     * Appointed advisers include former generals close to palaceUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)        Facebook seeks EU antitrust review of WhatsApp deal: sourceWRAPUP 3-Thai military rulers appoint anti-Thaksin advisersUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      UPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     * Appointed advisers include former generals close to palaceUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)       WRAPUP 3-Thai military rulers appoint anti-Thaksin advisersUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      UPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     * Appointed advisers include former generals close to palaceUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.WRAPUP 3-Thai military rulers appoint anti-Thaksin advisersUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      UPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     * Appointed advisers include former generals close to palaceUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)       May 28 Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceWRAPUP 3-Thai military rulers appoint anti-Thaksin advisersUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      UPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     * Appointed advisers include former generals close to palaceUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)       WRAPUP 3-Thai military rulers appoint anti-Thaksin advisersUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      UPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     * Appointed advisers include former generals close to palaceUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.WRAPUP 3-Thai military rulers appoint anti-Thaksin advisersUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)      UPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     * Appointed advisers include former generals close to palaceUPDATE 1-Thai ministry sparks alarm with brief block of FacebookThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)     Thai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    * Army says social media not blocked, blames gateway glitchThai ministry sparks alarm with brief block of FacebookFacebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)    Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   BANGKOK Thai Facebook users were alarmed on Wednesday when the Information Communications Technology (ICT) Ministry blocked access to the site at the request of the military, but the junta blamed the brief shutdown on a technical problem.Facebook seeks EU antitrust review of WhatsApp deal: sourceFacebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)   Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.Facebook seeks EU antitrust review of WhatsApp deal: sourceUPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)  UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon) Social network Facebook has asked European Union antitrust regulators to examine its $19 billion takeover of mobile messaging service WhatsApp, a person with direct knowledge of the matter said on Wednesday.UPDATE 1-Provincial attorney general denies reported Facebook CEO summoning - agency (Updates with attorney general denying Zuckerberg court summon)        
GE,GE offer for Alstom has improved, French official saysGE pledges 1,000 new French jobs as part of Alstom deal-sourceUPDATE 3-GE strengthens hand in Alstom battle with pledge on jobsGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    GE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   * GE pledges 1,000 new French jobs as part of deal - sourcesGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video     UPDATE 3-GE strengthens hand in Alstom battle with pledge on jobsGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    GE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   * GE pledges 1,000 new French jobs as part of deal - sourcesGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    PARIS, May 28 U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.UPDATE 3-GE strengthens hand in Alstom battle with pledge on jobsGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    GE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   * GE pledges 1,000 new French jobs as part of deal - sourcesGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video      GE pledges 1,000 new French jobs as part of Alstom deal-sourceUPDATE 3-GE strengthens hand in Alstom battle with pledge on jobsGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    GE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   * GE pledges 1,000 new French jobs as part of deal - sourcesGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video     UPDATE 3-GE strengthens hand in Alstom battle with pledge on jobsGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    GE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   * GE pledges 1,000 new French jobs as part of deal - sourcesGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    PARIS, May 28 U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.UPDATE 3-GE strengthens hand in Alstom battle with pledge on jobsGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    GE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   * GE pledges 1,000 new French jobs as part of deal - sourcesGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video     PARIS, May 28 U.S. conglomerate General Electric's offer for French train and turbines maker Alstom has been improved, notably concerning the impact on jobs, an official at French President Francois Hollande's office said on Wednesday.GE pledges 1,000 new French jobs as part of Alstom deal-sourceUPDATE 3-GE strengthens hand in Alstom battle with pledge on jobsGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    GE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   * GE pledges 1,000 new French jobs as part of deal - sourcesGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video     UPDATE 3-GE strengthens hand in Alstom battle with pledge on jobsGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    GE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   * GE pledges 1,000 new French jobs as part of deal - sourcesGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    PARIS, May 28 U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.UPDATE 3-GE strengthens hand in Alstom battle with pledge on jobsGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video    GE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   * GE pledges 1,000 new French jobs as part of deal - sourcesGE pledges 1,000 new French jobs as part of Alstom deal: sourceGE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video   GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video  PARIS U.S. conglomerate General Electric  is committed to creating 1,000 industrial jobs in France within three years to seal a deal to take over Alstom's  power arm, a source close to the talks told Reuters.GE strengthens hand in Alstom battle with pledge on jobs PARIS General Electric (GE)  strengthened its position in the battle for the power arm of French group Alstom  on Wednesday with a pledge to create new jobs in France and recognition from Paris that it had made a more acceptable offer. |Video      
GILD,TIMELINE-Early signs of pushback over U.S. drug pricesTimeline: Early signs of pushback over U.S. drug prices Gilead Sciences' $84,000 treatment for hepatitis C, Sovaldi, has broken the sales record for drug launches and caused a backlash among insurers concerned by the cost. Before the Sovaldi outcry, U.S. insurers and doctors made limited attempts to curb the rising cost of novel medicines.  Timeline: Early signs of pushback over U.S. drug prices Gilead Sciences' $84,000 treatment for hepatitis C, Sovaldi, has broken the sales record for drug launches and caused a backlash among insurers concerned by the cost. Before the Sovaldi outcry, U.S. insurers and doctors made limited attempts to curb the rising cost of novel medicines. May 28 Gilead Sciences' $84,000 treatment for hepatitis C, Sovaldi, has broken the sales record for drug launches and caused a backlash among insurers concerned by the cost. Before the Sovaldi outcry, U.S. insurers and doctors made limited attempts to curb the rising cost of novel medicines.Timeline: Early signs of pushback over U.S. drug prices Gilead Sciences' $84,000 treatment for hepatitis C, Sovaldi, has broken the sales record for drug launches and caused a backlash among insurers concerned by the cost. Before the Sovaldi outcry, U.S. insurers and doctors made limited attempts to curb the rising cost of novel medicines.  
GS,Goldman has cut bond trading staff by 10 pct since 2010-COOGoldman has cut bond trading staff by 10 percent since 2010: COO NEW YORK Goldman Sachs Group Inc has cut fixed-income trading staff by 10 percent since 2010 to reduce costs, President and Chief Operating Officer Gary Cohn said on Wednesday.  Goldman has cut bond trading staff by 10 percent since 2010: COO NEW YORK Goldman Sachs Group Inc has cut fixed-income trading staff by 10 percent since 2010 to reduce costs, President and Chief Operating Officer Gary Cohn said on Wednesday. NEW YORK, May 28 Goldman Sachs Group Inc  has cut fixed-income trading staff by 10 percent since 2010 to reduce costs, President and Chief Operating Officer Gary Cohn said on Wednesday.Goldman has cut bond trading staff by 10 percent since 2010: COO NEW YORK Goldman Sachs Group Inc has cut fixed-income trading staff by 10 percent since 2010 to reduce costs, President and Chief Operating Officer Gary Cohn said on Wednesday.  
INTC,Intel readies 3D-printed robots for handy consumers RANCHO PALOS VERDE, California, May 28 Intel Corp introduced a walking, talking robot on Wednesday made from 3D-printed parts that will be available to consumers later this year, if they are willing to assemble it with a kit that costs around $1,600. 
JNPR,Palo Alto reports 49 pct jump in revenue, settles lawsuit with JuniperUPDATE 2-Palo Alto revenue rises 49 pct, settles lawsuits with Juniper * Expects 4th-qtr revenue $158 mln-$162 mln vs est $158.4 mln  UPDATE 2-Palo Alto revenue rises 49 pct, settles lawsuits with Juniper * Expects 4th-qtr revenue $158 mln-$162 mln vs est $158.4 mln May 28 Security software maker Palo Alto Networks Inc reported a 49 percent jump in revenue, helped by higher subscriptions, and said it has settled all patent litigation with network gear maker Juniper Networks Inc .UPDATE 2-Palo Alto revenue rises 49 pct, settles lawsuits with Juniper * Expects 4th-qtr revenue $158 mln-$162 mln vs est $158.4 mln  
LLY,Sanofi, Lilly pursue Cialis over-the-counter approval PARIS, May 28 Sanofi and Eli Lilly and Co have agreed to pursue regulatory approval for over-the-counter sales of erectile dysfunction treatment Cialis, the French and U.S. drugmakers said in a statement on Wednesday. 
MPC,Marathon Petroleum Garyville refinery's partial shutdown due to power loss -officialMarathon confirms partial shutdown at Garyville, LA refinery due to power lossCORRECTED-UPDATE 1-Marathon Garyville, LA refinery partial shutdown due to power loss -local official (Corrects headline to indicate source was a local official, not Marathon)  CORRECTED-UPDATE 1-Marathon Garyville, LA refinery partial shutdown due to power loss -local official (Corrects headline to indicate source was a local official, not Marathon) May 28 Marathon Petroleum on Wednesday confirmed a partial shutdown of its Garyville, Louisiana, refinery due to power loss.CORRECTED-UPDATE 1-Marathon Garyville, LA refinery partial shutdown due to power loss -local official (Corrects headline to indicate source was a local official, not Marathon)   Marathon confirms partial shutdown at Garyville, LA refinery due to power lossCORRECTED-UPDATE 1-Marathon Garyville, LA refinery partial shutdown due to power loss -local official (Corrects headline to indicate source was a local official, not Marathon)  CORRECTED-UPDATE 1-Marathon Garyville, LA refinery partial shutdown due to power loss -local official (Corrects headline to indicate source was a local official, not Marathon) May 28 Marathon Petroleum on Wednesday confirmed a partial shutdown of its Garyville, Louisiana, refinery due to power loss.CORRECTED-UPDATE 1-Marathon Garyville, LA refinery partial shutdown due to power loss -local official (Corrects headline to indicate source was a local official, not Marathon)  May 28 Marathon Petroleum's Garyville, Louisiana, refinery experienced a power outage after a storm that knocked out electricity for more than 1,000 residents, according to a local official.Marathon confirms partial shutdown at Garyville, LA refinery due to power lossCORRECTED-UPDATE 1-Marathon Garyville, LA refinery partial shutdown due to power loss -local official (Corrects headline to indicate source was a local official, not Marathon)  CORRECTED-UPDATE 1-Marathon Garyville, LA refinery partial shutdown due to power loss -local official (Corrects headline to indicate source was a local official, not Marathon) May 28 Marathon Petroleum on Wednesday confirmed a partial shutdown of its Garyville, Louisiana, refinery due to power loss.CORRECTED-UPDATE 1-Marathon Garyville, LA refinery partial shutdown due to power loss -local official (Corrects headline to indicate source was a local official, not Marathon)   
MA,MasterCard extends zero liability policy to ATM transactionsUPDATE 2-MasterCard extends zero-liability policy to ATM transactions * Cards issued in U.S. to have identity theft resolution assistance  UPDATE 2-MasterCard extends zero-liability policy to ATM transactions * Cards issued in U.S. to have identity theft resolution assistance May 28 MasterCard Inc, the world's second largest debit and credit card company, said it was extending its zero liability policy in the United States to include all PIN-based and ATM transactions.UPDATE 2-MasterCard extends zero-liability policy to ATM transactions * Cards issued in U.S. to have identity theft resolution assistance  
MDT,BRIEF-Medtronic settles U.S. charges over alleged kickbacks to doctorsMedtronic settles U.S. kickbacks case over pacemakersUPDATE 1-Medtronic settles U.S. kickbacks case over pacemakers May 28 Medtronic Inc has agreed to pay the United States $9.9 million to settle claims that the company used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients, the U.S. Department of Justice said.  UPDATE 1-Medtronic settles U.S. kickbacks case over pacemakers May 28 Medtronic Inc has agreed to pay the United States $9.9 million to settle claims that the company used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients, the U.S. Department of Justice said. May 28 Medtronic Inc has agreed to pay $9.9 million to the United States to settle claims it used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients.UPDATE 1-Medtronic settles U.S. kickbacks case over pacemakers May 28 Medtronic Inc has agreed to pay the United States $9.9 million to settle claims that the company used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients, the U.S. Department of Justice said.   Medtronic settles U.S. kickbacks case over pacemakersUPDATE 1-Medtronic settles U.S. kickbacks case over pacemakers May 28 Medtronic Inc has agreed to pay the United States $9.9 million to settle claims that the company used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients, the U.S. Department of Justice said.  UPDATE 1-Medtronic settles U.S. kickbacks case over pacemakers May 28 Medtronic Inc has agreed to pay the United States $9.9 million to settle claims that the company used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients, the U.S. Department of Justice said. May 28 Medtronic Inc has agreed to pay $9.9 million to the United States to settle claims it used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients.UPDATE 1-Medtronic settles U.S. kickbacks case over pacemakers May 28 Medtronic Inc has agreed to pay the United States $9.9 million to settle claims that the company used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients, the U.S. Department of Justice said.  May 28 Medtronic Inc :  * U.S. says Medtronic Inc to pay $9.9 million to resolve claims underMedtronic settles U.S. kickbacks case over pacemakersUPDATE 1-Medtronic settles U.S. kickbacks case over pacemakers May 28 Medtronic Inc has agreed to pay the United States $9.9 million to settle claims that the company used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients, the U.S. Department of Justice said.  UPDATE 1-Medtronic settles U.S. kickbacks case over pacemakers May 28 Medtronic Inc has agreed to pay the United States $9.9 million to settle claims that the company used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients, the U.S. Department of Justice said. May 28 Medtronic Inc has agreed to pay $9.9 million to the United States to settle claims it used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients.UPDATE 1-Medtronic settles U.S. kickbacks case over pacemakers May 28 Medtronic Inc has agreed to pay the United States $9.9 million to settle claims that the company used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients, the U.S. Department of Justice said.   
MRK,UPDATE 1-Sanofi, Lilly pursue Cialis over-the-counter approval NEW YORK, May 28 Sanofi and Eli Lilly and Co on Wednesday said they would ask health regulators for permission to sell Cialis, the world's top-selling anti-impotence drug, without a prescription. 
MSFT,Microsoft shows off real-time Skype translatorSome young spellers relieved by early elimination from U.S. bee OXON HILL, Md., May 28 Twelve-year-old Nathan Manaker had not been hopeful about his chances when the Scripps National Spelling Bee got under way on Wednesday, and he turned out to be right.  Some young spellers relieved by early elimination from U.S. bee OXON HILL, Md., May 28 Twelve-year-old Nathan Manaker had not been hopeful about his chances when the Scripps National Spelling Bee got under way on Wednesday, and he turned out to be right. RANCHO PALOS VERDES, Calif., May 27 Microsoft Corp showed off a test version of a real-time, spoken-word translation service for Skype calls on Tuesday, the first time the world's largest software company has demonstrated the breakthrough technology publicly in the United States.Some young spellers relieved by early elimination from U.S. bee OXON HILL, Md., May 28 Twelve-year-old Nathan Manaker had not been hopeful about his chances when the Scripps National Spelling Bee got under way on Wednesday, and he turned out to be right.  
PFE,UPDATE 1-Boehringer to settle lawsuits against blockbuster drug for $650 mlnBoehringer to settle lawsuits against blockbuster drug for $650 millionItaly seeks anti-trust compensation from Roche, Novartis, PfizerUPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   ROME, May 28 Italy said on Wednesday it was seeking billion euro pay-outs from multinational drug companies following a ruling by the country's anti-trust authority that their unfair policies had been detrimental to Italy's national health service.UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)     Italy seeks anti-trust compensation from Roche, Novartis, PfizerUPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   ROME, May 28 Italy said on Wednesday it was seeking billion euro pay-outs from multinational drug companies following a ruling by the country's anti-trust authority that their unfair policies had been detrimental to Italy's national health service.UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    German drugmaker Boehringer Ingelheim said on Wednesday it would pay about $650 million to settle U.S. lawsuits that claimed the company's blockbuster blood thinner, Pradaxa, had caused severe and fatal bleeding in patients.Italy seeks anti-trust compensation from Roche, Novartis, PfizerUPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   ROME, May 28 Italy said on Wednesday it was seeking billion euro pay-outs from multinational drug companies following a ruling by the country's anti-trust authority that their unfair policies had been detrimental to Italy's national health service.UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)      Boehringer to settle lawsuits against blockbuster drug for $650 millionItaly seeks anti-trust compensation from Roche, Novartis, PfizerUPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   ROME, May 28 Italy said on Wednesday it was seeking billion euro pay-outs from multinational drug companies following a ruling by the country's anti-trust authority that their unfair policies had been detrimental to Italy's national health service.UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)     Italy seeks anti-trust compensation from Roche, Novartis, PfizerUPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   ROME, May 28 Italy said on Wednesday it was seeking billion euro pay-outs from multinational drug companies following a ruling by the country's anti-trust authority that their unfair policies had been detrimental to Italy's national health service.UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    German drugmaker Boehringer Ingelheim said on Wednesday it would pay about $650 million to settle U.S. lawsuits that claimed the company's blockbuster blood thinner, Pradaxa, had caused severe and fatal bleeding in patients.Italy seeks anti-trust compensation from Roche, Novartis, PfizerUPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   ROME, May 28 Italy said on Wednesday it was seeking billion euro pay-outs from multinational drug companies following a ruling by the country's anti-trust authority that their unfair policies had been detrimental to Italy's national health service.UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)     (Adds comment from plaintiffs' lawyer and company's denial of liability)Boehringer to settle lawsuits against blockbuster drug for $650 millionItaly seeks anti-trust compensation from Roche, Novartis, PfizerUPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   ROME, May 28 Italy said on Wednesday it was seeking billion euro pay-outs from multinational drug companies following a ruling by the country's anti-trust authority that their unfair policies had been detrimental to Italy's national health service.UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)     Italy seeks anti-trust compensation from Roche, Novartis, PfizerUPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   ROME, May 28 Italy said on Wednesday it was seeking billion euro pay-outs from multinational drug companies following a ruling by the country's anti-trust authority that their unfair policies had been detrimental to Italy's national health service.UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    German drugmaker Boehringer Ingelheim said on Wednesday it would pay about $650 million to settle U.S. lawsuits that claimed the company's blockbuster blood thinner, Pradaxa, had caused severe and fatal bleeding in patients.Italy seeks anti-trust compensation from Roche, Novartis, PfizerUPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)    UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   ROME, May 28 Italy said on Wednesday it was seeking billion euro pay-outs from multinational drug companies following a ruling by the country's anti-trust authority that their unfair policies had been detrimental to Italy's national health service.UPDATE 2-Italy seeks anti-trust compensation from Roche, Novartis, PfizerCORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)   CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  ROME, May 28 Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service.CORRECTED-INSIGHT-Insurers scrutinize drug costs after $84,000 Sovaldi surpriseCORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)  CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller) (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)CORRECTED-INSIGHT-RPT-Insurers scrutinize drug costs after $84,000 Sovaldi surprise (Corrects to Reimbursement Intelligence from Intelligence Reimbursement, to Whang as co-president from president, to Steve Miller from Stuart Miller)      
STJ,St. Jude to acquire CardioMEMS following FDA approval of device May 28 St. Jude Medical Inc said on Wednesday it plans to exercise its option to buy the shares of CardioMEMS it does not already own for $375 million following news the Food and Drug Administration has approved CardioMEMS's wireless heart device. 
SYK,Smith & Nephew surges on report of Stryker bidUPDATE 2-U.S. group Stryker denies planning Smith & Nephew bidStryker denies planning Smith & Nephew bidGlaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  LONDON U.S. medical devices manufacturer Stryker Corp SYK.N has denied any intention of making a bid for UK rival Smith & Nephew Plc SN.L, whose shares had spiked higher after a report that Stryker was planning a bid.Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation    Stryker denies planning Smith & Nephew bidGlaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  LONDON U.S. medical devices manufacturer Stryker Corp SYK.N has denied any intention of making a bid for UK rival Smith & Nephew Plc SN.L, whose shares had spiked higher after a report that Stryker was planning a bid.Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   LONDON, May 28 U.S. medical devices manufacturer Stryker Corp has denied any intention of making a bid for UK rival Smith & Nephew Plc, whose shares had spiked higher after a report that Stryker was planning a bid.Stryker denies planning Smith & Nephew bidGlaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  LONDON U.S. medical devices manufacturer Stryker Corp SYK.N has denied any intention of making a bid for UK rival Smith & Nephew Plc SN.L, whose shares had spiked higher after a report that Stryker was planning a bid.Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation     UPDATE 2-U.S. group Stryker denies planning Smith & Nephew bidStryker denies planning Smith & Nephew bidGlaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  LONDON U.S. medical devices manufacturer Stryker Corp SYK.N has denied any intention of making a bid for UK rival Smith & Nephew Plc SN.L, whose shares had spiked higher after a report that Stryker was planning a bid.Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation    Stryker denies planning Smith & Nephew bidGlaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  LONDON U.S. medical devices manufacturer Stryker Corp SYK.N has denied any intention of making a bid for UK rival Smith & Nephew Plc SN.L, whose shares had spiked higher after a report that Stryker was planning a bid.Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   LONDON, May 28 U.S. medical devices manufacturer Stryker Corp has denied any intention of making a bid for UK rival Smith & Nephew Plc, whose shares had spiked higher after a report that Stryker was planning a bid.Stryker denies planning Smith & Nephew bidGlaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  LONDON U.S. medical devices manufacturer Stryker Corp SYK.N has denied any intention of making a bid for UK rival Smith & Nephew Plc SN.L, whose shares had spiked higher after a report that Stryker was planning a bid.Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation    LONDON Shares in Europe's largest maker of artificial joints, Smith & Nephew , surged 11 percent on Wednesday on speculation about a possible takeover offer from U.S. rival Stryker , traders said.UPDATE 2-U.S. group Stryker denies planning Smith & Nephew bidStryker denies planning Smith & Nephew bidGlaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  LONDON U.S. medical devices manufacturer Stryker Corp SYK.N has denied any intention of making a bid for UK rival Smith & Nephew Plc SN.L, whose shares had spiked higher after a report that Stryker was planning a bid.Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation    Stryker denies planning Smith & Nephew bidGlaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  LONDON U.S. medical devices manufacturer Stryker Corp SYK.N has denied any intention of making a bid for UK rival Smith & Nephew Plc SN.L, whose shares had spiked higher after a report that Stryker was planning a bid.Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   LONDON, May 28 U.S. medical devices manufacturer Stryker Corp has denied any intention of making a bid for UK rival Smith & Nephew Plc, whose shares had spiked higher after a report that Stryker was planning a bid.Stryker denies planning Smith & Nephew bidGlaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation   Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  LONDON U.S. medical devices manufacturer Stryker Corp SYK.N has denied any intention of making a bid for UK rival Smith & Nephew Plc SN.L, whose shares had spiked higher after a report that Stryker was planning a bid.Glaxo investigation pegs back Britain's FTSEGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation  Glaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation * Glaxo falls after fraud office opens criminal investigationGlaxo probe pegs back Britain's FTSE * Glaxo falls after fraud office opens criminal investigation     
YHOO,Alibaba to disclose names of 28 major shareholders - WSJ May 28 Alibaba Group Holding Ltd  will name the 28 people who will control the world's biggest e-commerce firm in an update to its initial public offering filing, the Wall Street Journal said, quoting people familiar with the plans. 
